Cargando…

Multidimensional analysis of behavior predicts genotype with high accuracy in a mouse model of Angelman syndrome

Angelman syndrome (AS) is a neurodevelopmental disorder caused by loss of expression of the maternal copy of the UBE3A gene. Individuals with AS have a multifaceted behavioral phenotype consisting of deficits in motor function, epilepsy, cognitive impairment, sleep abnormalities, as well as other co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanas, Joseph K., Kerr, Devante D., Wang, Li, Rai, Anika, Wallaard, Ilse, Elgersma, Ype, Sidorov, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529912/ https://www.ncbi.nlm.nih.gov/pubmed/36192373 http://dx.doi.org/10.1038/s41398-022-02206-3

Ejemplares similares

A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
por: Sonzogni, Monica, et al.
Publicado: (2018)

Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model
por: Milazzo, Claudia, et al.
Publicado: (2021)

UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021)

Enhanced Transmission at the Calyx of Held Synapse in a Mouse Model for Angelman Syndrome
por: Wang, Tiantian, et al.
Publicado: (2018)

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
por: Sonzogni, Monica, et al.
Publicado: (2020)

The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
por: Viho, Eva M. G., et al.
Publicado: (2022)

From first report to clinical trials: a bibliometric overview and visualization of the development of Angelman syndrome research
por: Zampeta, F. Isabella, et al.
Publicado: (2022)

Calmodulin kinase II regulates amphetamine-induced reverse transport in the dopamine transporter: implications for the importance of the dopamine transporter in Angelman syndrome
por: Steinkellner, Thomas, et al.
Publicado: (2010)

Clinical aspects of a large group of adults with Angelman syndrome
por: den Besten, Inge, et al.
Publicado: (2020)

Hyperphagia, Growth, and Puberty in Children with Angelman Syndrome
por: Bindels-de Heus, Karen G. C. B., et al.
Publicado: (2023)

UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation
por: Rotaru, Diana C., et al.
Publicado: (2023)

Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
por: Sonzogni, Monica, et al.
Publicado: (2019)

Identifying the temporal electrophysiological and molecular changes that contribute to TSC-associated epileptogenesis
por: Koene, Linda M.C., et al.
Publicado: (2021)

Genotype–Phenotype Correlations in Angelman Syndrome
por: Yang, Lili, et al.
Publicado: (2021)

Adult Camk2a gene reinstatement restores the learning and plasticity deficits of Camk2a knockout mice
por: Rigter, Pomme M.F., et al.
Publicado: (2022)

Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
por: Judson, Matthew C., et al.
Publicado: (2021)

Effects of antiepileptic drugs in a new TSC/mTOR‐dependent epilepsy mouse model
por: Koene, Linda M. C., et al.
Publicado: (2019)

Aberrant aggressive behavior in a mouse model of Angelman syndrome
por: Simchi, Lilach, et al.
Publicado: (2021)

An overview of health issues and development in a large clinical cohort of children with Angelman syndrome
por: Bindels‐de Heus, Karen G. C. B., et al.
Publicado: (2019)

Behavior and neuropsychiatric manifestations in Angelman syndrome
por: Pelc, Karine, et al.
Publicado: (2008)

Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
por: Bossuyt, Stijn N V, et al.
Publicado: (2021)

Ca(2+)/Calmodulin-dependent Protein Kinase IIα (αCaMKII) Controls the Activity of the Dopamine Transporter: IMPLICATIONS FOR ANGELMAN SYNDROME
por: Steinkellner, Thomas, et al.
Publicado: (2012)

Communication‐related assessments in an Angelman syndrome mouse model
por: Perrino, Peter A., et al.
Publicado: (2020)

Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis
por: Sidorov, Michael S., et al.
Publicado: (2017)

Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep
por: Levin, Yuval, et al.
Publicado: (2022)

Angelman Syndrome and Angelman-like Syndromes Share the Same Calcium-Related Gene Signatures
por: Panov, Julia, et al.
Publicado: (2021)

Erratum to: Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis
por: Sidorov, Michael S., et al.
Publicado: (2017)

Dissociating motor impairment from five-choice serial reaction time task performance in a mouse model of Angelman syndrome
por: Negrón-Moreno, Paola N., et al.
Publicado: (2022)

A brain proteomic investigation of rapamycin effects in the Tsc1(+/−) mouse model
por: Wesseling, Hendrik, et al.
Publicado: (2017)

Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment
por: Keute, Marius, et al.
Publicado: (2020)

An Analysis of Phenotype and Genotype in a Large Cohort of Chinese Children with Angelman Syndrome
por: Du, Xiaonan, et al.
Publicado: (2022)

Epilepsy in patients with Angelman syndrome
por: Fiumara, Agata, et al.
Publicado: (2010)

Neurodevelopmental Underpinnings of Angelman Syndrome
por: Li, Guohui, et al.
Publicado: (2014)

Angelman syndrome and anaesthetic considerations
por: Agarwal, Jyotsna, et al.
Publicado: (2017)

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry
por: Napier, Kathryn R., et al.
Publicado: (2017)

A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
por: Geerts‐Haages, Amber, et al.
Publicado: (2020)

Normal social seeking behavior, hypoactivity and reduced exploratory range in a mouse model of Angelman syndrome
por: Allensworth, Melody, et al.
Publicado: (2011)

Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse
por: Kumar, Vipendra, et al.
Publicado: (2019)

Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model
por: Filonova, Irina, et al.
Publicado: (2014)

Healthcare burden among individuals with Angelman syndrome: Findings from the Angelman Syndrome Natural History Study
por: Khan, Nasreen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rd3tbt7kejg35j39o32t0rk3er